FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live CADILAHC message board: Is CADILAHC buy or sell? Should I buy CADILAHC shares? Why are CADILAHC shares falling? Should I invest in CADILAHC stock?

forum

CADILAHC Share Price Discussion

Cadila Healthcare Ltd.
NSE: CADILAHC | BSE: 532321 | ISIN: INE010B01027 | Sector: Pharmaceuticals and health care
Jsm > CADILAHC > Post
J
Reputation: -23,694 • Jun 2 7:00 AM


Type
Sell
Instrument
CADILAHC JUN20 FUT
Entry Price
₹356.85
Price@Trade
₹356.85
Target Price
₹340
Stop Price
₹369
Valid Till
Jun 25, 2020 3:20 AM
Margin
₹207,727.3 approx for 2200 Qty
Status
Exited
Exit Price
₹355
Net P&L
+₹4,070 (+1.96%)
Like
Reply (1)
NSE:CADILAHC price when posted: 356.55
1 Replies
Jsm @JSMConsulting
Jun 2 7:35 AM

Update
Exited
Exit Price
₹355
Net P&L
+₹4,070 (+1.96%)
Recent posts in CADILAHC
N
Reputation: 3,821 • Yesterday 5:41 AM
Cadila Healthcare jumps 5% on receiving nod for human trials of Covid-19 drug
The approval process was fast-tracked, following recommendation by the subject expert committee and considering the emergency and unmet medical need during the pandemic.
The Economic Times
Like
Reply

Type
Sell
Instrument
CADILAHC
Entry Price
₹363.85
Price@Trade
₹363.85
Target Price
₹331.75
Stop Price
₹379.6
Valid Till
Jul 3, 2020 3:20 AM
Margin
₹99,694.9 approx for 274 Qty
Status
Validity Over
Exit Price
₹365.2
Net P&L
-₹369.9 (-0.37%)
Like
Reply (1)
N
Reputation: 3,821 • Yesterday 4:51 AM
Zydus says potential COVID-19 vaccine gets DGCI nod for human trials
ZyCoV-D, developed at the company's Vaccine Technology Centre in Ahmedabad, has now received permission from the Drug Controller General of India (DGCI) - Central Drugs Standard Control Organisation (CDSCO) to initiate phase I/II human clinical trials in India, Cadila Healthcare said in a regulatory filing.
The Economic Times
Like
Reply
P
Reputation: -507 • Yesterday 4:25 AM

Cadila Healthcare is currently trading at Rs. 366.95, up by 3.70 points or 1.02% from its previous closing of Rs. 363.25 on the BSE.

The scrip opened at Rs. 379.80 and has touched a high and low of Rs. 380.00 and Rs. 364.00 respectively. So far 166075 shares were traded on the c...
Read more...
Like
Reply
M
Reputation: 9,058 • Yesterday 3:17 AM

Type
Buy
Instrument
CADILAHC JUL20 400 CE
Entry Price
₹8.75
Price@Trade
₹8.75
Target Price
₹20
Stop Price
₹1
Valid Till
Jul 30, 2020 3:20 AM
Margin
₹19,250 approx for 2200 Qty
Status
Active
Like
Reply
N
Reputation: 3,821 • Yesterday 2:46 AM
COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials
The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity, sources said.
The Economic Times
Like
Reply